1.90% -0.365

Viridian Therapeutics Inc (VRDN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Viridian Therapeutics Inc Azioni (VRDN) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	4.17% 0.075	0.072	0.086	0.072	0.072
Operating Expenses	13.74% 106.84	93.94	83.57	72.26	55.97
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	13.74% 106.84	93.94	83.57	72.26	55.97
Operating Income/Loss	13.74% -106.77	-93.87	-83.48	-72.19	-55.90
Nonoperating Income/Loss	13.26% 6.032	6.954	6.791	7.194	7.355
Income/Loss From Continuing Operations Before Tax	100.09% 0.075	-86.91	0.086	-64.99	-48.54
Income/Loss From Continuing Operations After Tax	15.90% -100.73	-86.91	-76.69	-64.99	-48.54
Net Income/Loss	15.90% -100.73	-86.91	-76.69	-64.99	-48.54
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$35.83

1.66%

INCY

$85.75

1.10%

GMAB

$31.46

2.62%

BNTX

$102.62

4.05%

INSM

$144.22

0.15%

ONC

$342.98

0.67%